Belpointe Asset Management LLC Vir Biotechnology, Inc. Transaction History

Belpointe Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $1,736 - $2,406	78 Added 78.79%	177 $4,000
Q4 2022 Feb 08, 2023	BUY	$19.96 - $28.22 $1,976 - $2,793	99 New	99 $2,000
Q4 2021 Feb 15, 2022	SELL	$30.97 - $54.03 $777,316 - $1.36 Million	-25,099 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $875,955 - $1.37 Million	25,099 New	25,099 $1.09 Million
Q1 2021 May 14, 2021	SELL	$26.34 - $83.07 $541,524 - $1.71 Million	-20,559 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.51 - $43.38 $524,460 - $891,849	20,559 New	20,559 $551,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.